ovarian neoplasms
Showing 51 - 75 of 220
Ovarian Tumors Trial in Chongqing
Recruiting
- Ovarian Neoplasms
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 12, 2022
Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)
Active, not recruiting
- Ovarian Cancer
- +9 more
-
Berlin, Germany
- +14 more
Mar 10, 2022
Ovarian Tumors Trial (Combined Oral Contraceptive, Progestin)
Not yet recruiting
- Ovarian Neoplasms
- Combined Oral Contraceptive
- Progestin
- (no location specified)
Feb 8, 2022
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or
Terminated
- Ovarian Cancer
- Ovarian Neoplasms
- 18F-EF5 PET/CT scan
- Optional biopsy
-
Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
Feb 2, 2022
Retrospective Study of Brachytherapy
Recruiting
- Brachytherapy
- +6 more
- Brachytherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Feb 6, 2022
Ovarian Tumors, Platinum Sensitive Ovarian Cancer Trial in Worldwide (Active comparator: Niraparib, )
Completed
- Ovarian Neoplasms
- Platinum Sensitive Ovarian Cancer
- Active comparator: Niraparib
- placebo
-
Phoenix, Arizona
- +111 more
Jan 28, 2022
HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)
Recruiting
- HER2-positive
- +30 more
- CT-0508
-
Duarte, California
- +4 more
Feb 1, 2022
First-line Olaparib Mono-maintenancerapy-a Multicenter,
Not yet recruiting
- Ovarian Neoplasms
- Olaparib mono-maintenance therapy
- (no location specified)
Dec 8, 2021
Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,
Completed
- Neoplasms, Breast
- +5 more
- niraparib
- Physician's choice
-
Tucson, Arizona
- +103 more
Nov 2, 2021
Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian
Completed
- Ovarian Neoplasms
-
Matsuyama, Ehime, Japan
- +19 more
Oct 19, 2021
Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)
Completed
- Ovarian Neoplasms
- Ovarian Cancer
-
Chandler, Arizona
- +54 more
Sep 24, 2021
DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using
Recruiting
- Ovarian Neoplasms
- +8 more
-
Montreal, Quebec, Canada
- +1 more
Oct 14, 2021
DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
Recruiting
- Ovarian Neoplasms
- Blood test: CA-125 biomarker
- +2 more
-
Kirkland, Quebec, Canada
- +7 more
Oct 14, 2021
Ovarian Germ Cell Cancer, Ovarian Tumors, Ovarian Cancer Trial in Jinan (Paclitaxel, Carboplatin, Bleomycin)
Recruiting
- Ovarian Germ Cell Cancer
- +2 more
- Paclitaxel
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Oct 7, 2021
Ovarian Sex Cord Stromal Tumor, Ovarian Tumors, Ovarian Cancer Trial in Jinan (Paclitaxel, Carboplatin, Bleomycin)
Recruiting
- Ovarian Sex Cord Stromal Tumor
- +2 more
- Paclitaxel
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Oct 7, 2021
An INternational Frontline Ovarian Cancer Real World Management
Completed
- Ovarian Neoplasms
-
Melbourne, Victoria, Australia
- +3 more
Sep 22, 2021
Ovarian Tumors Trial in Lexington (Abnormal Ovarian Ultrasound)
Recruiting
- Ovarian Neoplasms
- Abnormal Ovarian Ultrasound
-
Lexington, KentuckyMarkey Cancer Center, University of Kentucky
Sep 9, 2021
Protein P16 Expression in Ovarian Germ Cell Tumors.
Completed
- Ovarian Neoplasms
- +2 more
- p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
- Ki67 antibody (DAKO) for malignant cases only
-
Assiut, EgyptAssiut University
Aug 12, 2021
Establishment of a Tumor Bank for Blood Samples
Recruiting
- Ovarian Neoplasms
- +5 more
- Blood collection
-
Innsbruck, Austria
- +5 more
Aug 30, 2021
Establishment of a Tumor Bank for Tissue Samples
Recruiting
- Ovarian Neoplasms
- +5 more
- Tumor tissue collection
- +6 more
-
Vienna, Austria
- +2 more
Aug 30, 2021
Ovarian Cancer, Ovarian Tumors Trial in Baltimore, Durham, Charlottesville (Atezolizumab, Carboplatin, Paclitaxel)
Completed
- Ovarian Cancer
- Ovarian Neoplasms
- Atezolizumab
- +3 more
-
Baltimore, Maryland
- +2 more
Aug 10, 2021
Ovarian Tumors Trial in Netherlands (ctDNA - circulating tumor DNA, TEP - Tumor Educated Platelets)
Recruiting
- Ovarian Neoplasms
- ctDNA - circulating tumor DNA
- TEP - Tumor Educated Platelets
-
Amsterdam-Zuidoost, Netherlands
- +3 more
Jul 20, 2021
Ascertainment of Peripheral Blood or Saliva Samples for Genetic
Active, not recruiting
- Breast Neoplasms
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 14, 2021
Ovarian Tumors, Tumors, Solid Tumor Trial in United States (Niraparib)
Completed
- Ovarian Neoplasms
- +3 more
-
Los Angeles, California
- +4 more
May 4, 2021